Exicure Inc is a biotechnology company that has historically focused on developing nucleic acid therapies targeting RNA against validated targets. It acquired a clinical-stage biotechnology company in January 2025 and is exploring strategic alternatives to maximize stockholder value.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.